Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,279,293 | 1,112,232 | 1,396,044 | 975,559 | 818,701 |
| Marketable Securities | 1,651,961 | 1,351,071 | 1,346,589 | 912,343 | 1,095,491 |
| Receivables | 300,533 | 415,478 | 319,495 | 939,224 | 166,901 |
| Other current assets | 1 | 0 | 0 | 0 | 0 |
| TOTAL | $3,231,788 | $2,878,781 | $3,062,128 | $2,827,126 | $2,081,093 |
| Non-Current Assets | |||||
| PPE Net | 81,861 | 69,400 | 68,766 | 61,148 | 47,412 |
| Investments And Advances | 146,701 | 165,609 | 101,579 | 22,450 | 22,007 |
| Intangibles | 51,386 | 51,782 | 60,445 | 61,000 | 65,283 |
| Other Non-Current Assets | 88,507 | 73,536 | 86,036 | 83,155 | 44,458 |
| TOTAL | $368,453 | $360,326 | $316,826 | $227,753 | $179,160 |
| Total Assets | $3,600,241 | $3,239,108 | $3,378,954 | $3,054,879 | $2,260,253 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 185,605 | 181,542 | 151,348 | 126,284 | 99,698 |
| TOTAL | $209,595 | $191,960 | $354,506 | $296,729 | $109,298 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,215 | 3,983 | 4,082 | 3,840 | N/A |
| Other Non-Current Liabilities | 54,304 | 43,202 | 47,100 | 46,673 | 24,371 |
| TOTAL | $133,246 | $117,811 | $123,559 | $118,603 | $24,371 |
| Total Liabilities | $342,842 | $309,770 | $478,065 | $415,332 | $133,669 |
| Shareholders' Equity | |||||
| Common Shares | 10,699 | 10,111 | 10,205 | 9,601 | 9,601 |
| Retained earnings | 1,300,042 | 1,088,792 | 1,014,691 | 868,771 | 358,911 |
| Other shareholders' equity | 15,399 | 8,273 | 11,618 | 14,475 | 15,805 |
| TOTAL | $3,257,399 | $2,929,337 | $2,900,889 | $2,639,547 | $2,126,585 |
| Total Liabilities And Equity | $3,600,241 | $3,239,107 | $3,378,954 | $3,054,879 | $2,260,254 |